How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?

This is an excellent question and one we confront regularly. This is another of what I call “happy problems” because it is a consequence of increasing options for effective therapy for our patients.

Tocilizumab is clearly an effective agent for some patients with giant cell arteritis (GCA), and patie...